Just Eat Reports Q3 Trading Update With U.S. Behind
We expect Grubhub's fundamentals to recover in line with back-to-office trends.
Just Eat Takeaway reported third-quarter 2021 results with orders and general transaction value up 25% and 23% respectively. Within this, although order growth was somewhat lower than expected at the group level, Grubhub grew orders by 3% (marketplace orders down 23% while delivery orders up 23%) and management said the firm is rolling out an improvement program to refocus the business on Grubhub's strongholds. Another important consideration here is that a substantial portion of the business is in the office channel in big metro cities like New York City and Boston. Looking at subway usage rates (MTA turnstile data), third-quarter usage has been about 11 million per week versus 35 million on average precoronavirus, which could potentially explain sluggish growth rates for Grubhub. We expect Grubhub's fundamentals to recover in line with back-to-office trends. Excluding its U.S. business, marketplace orders (which restaurants deliver themselves) were up 13% (notably up 33% in Germany) in the third quarter and up 25% year to date (versus up 27% for the year in our model), while delivery orders continue to drive growth for the group (up 88% excluding Grubhub and 58% for the group). Management reiterated guidance of more than 45% order growth excluding Grubhub, fiscal 2021 adjusted EBITDA margin of negative 1% to 1.50% (EUR 360 million EBITDA loss at the midpoint) and gross transaction value of EUR 28 billion-30 billion (including Grubhub). For the company to deliver on order guidance (more than 45% excluding Grubhub), in our estimates it will have to achieve more than 30% order growth in the fourth quarter (versus a tough comparable of 56% last year). We don't anticipate significantly changing our fair value estimate for Just Eat Takeaway. We intend to refresh our model and estimates after the company's capital market day on Oct. 21. Shares trade deep in 5-star territory, presenting a material opportunity with a strong margin of safety for patient investors.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.